Fresh Tracks Therapeutics Inc (NASDAQ:FRTX)
| 0.6558 Delayed Data As of Mar 31 |  -0.0448 / -6.39%Today’s Change | 0.64 Today|||52-Week Range 18.95 | -56.28% Year-to-Date |
Latest FRTX News | Press Releases
No recent news for Fresh Tracks Therapeutics Inc.
Today’s Trading
| Previous close | 0.70 |
| Today’s open | 0.69 |
| Day’s range | 0.65 - 0.69 |
| Volume | 1,790 |
| Average volume (3 months) | 621,454 |
| Market cap | $3.9M |
Data as of 3:20pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +66.02% |
| Earnings growth (this year) | +27.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,618.56% |
| P/E ratio | NM |
| Price/Sales | 0.61 |
| Price/Book | 0.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PLXPPLx Pharma Inc | -0.01 | -8.27% |
| ---- | ||
| QLGNQualigen Therapeutic... | +0.00 | +0.45% |
| --Orphazyme A/S | 0.00 | 0.00% |
Data as of 3:59pm ET, 03/31/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$1.65 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$21.1M |
| Net profit margin | -303.93% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
